COO

Cooper Companies Inc.

Price

$61.47

return (12m)

-16.39%

p/e

20.73

p/bv

1.42

DIVIDEND YIELD

0.00%

COO price

Cooper Companies

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment COO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.49%

3 months

-14.37%

1 year

-16.39%

2 years

-42.99%

5 years

-40.30%

10 years

40.40%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals COO

Valuation

P/E

20.73

Sector 0.88

Industry 3.36

P/BV

1.42

Sector 1.82

Industry 2.08

P/Revenue (PSR)

2.79

Sector 1.49

Industry 1.65

EV/EBITDA

14.64

Sector -45.42

Industry 1.46

EV/EBIT

24.97

Sector -48.36

Industry -4.97

P/EBITDA

12.74

Sector -30.89

Industry -49.47

P/EBIT

21.73

Sector -34.27

Industry -46.45

P/Total Assets

0.93

Sector 0.82

Industry 0.92

P/Net Current Assets

-5.73

Sector -23.91

Industry -9.30

P/Working Capital

28.50

Sector -3.81

Industry 2.66

EPS

2.95

Sector -0.70

Industry -0.60

BVPS

43.15

Sector 4.50

Industry 4.74

Efficiency

Gross Margin

65.93%

Sector 49.33%

Industry 50.68%

EBITDA Margin

30.32%

Sector -236.80%

Industry -51.91%

EBIT Margin

12.84%

Sector -19.73%

Industry -25.80%

Net Profit Margins

13.46%

Sector -23.90%

Industry -29.17%

Asset Turnover

0.08

Sector 0.13

Industry 0.15

Profitability

ROE

6.85%

Sector -24.31%

Industry -22.30%

ROA

4.50%

Sector -24.50%

Industry -24.15%

ROIC

7.50%

Sector -514.78%

Industry -94.48%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.22

Sector 1.92

Industry 1.98

Net Debt / EBITDA

1.90

Sector -21.25

Industry -2.11

Net Debt / EBIT

3.24

Sector -17.49

Industry -1.59

Net Debt / Equity

0.21

Sector -0.99

Industry -0.29

Gross Debt / Equity

0.23

Sector -0.73

Industry -0.82

Equity/Assets

0.66

Sector 0.46

Industry 0.47

Liabilities/Assets

0.34

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

7.71%

Sector -

Industry -

5Y Earnings CAGR

-27.99%

Sector -

Industry -

Fundamentals COO

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Cooper Companies ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$61.47

Fair Value

$53.52

Upside

-12.93%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
COO Cooper Companies Inc.	$61.47	-16.39%	0.00%	20.73	1.42	6.85%	13.46%
ABT Abbott Laboratories	$104.61	-15.11%	2.39%	32.43	0.00	-%	11.52%
MDT Medtronic PLC	$94.55	4.27%	2.98%	23.51	2.42	10.29%	13.93%
BSX Boston Scientific Corp.	$45.40	-55.10%	0.00%	18.43	2.71	14.73%	17.49%
TMDX TransMedics Group Inc.	$71.61	-45.13%	0.00%	16.39	4.80	29.28%	22.69%
RMD ResMed Inc.	$253.07	-1.44%	0.96%	24.27	5.61	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$569.61	-11.12%	0.00%	38.97	27.54	70.67%	25.03%
COHR Coherent Inc.	$220.73	70.65%	0.00%	51.26	3.67	7.16%	11.31%
SYK Stryker Corp.	$305.18	-19.00%	1.13%	31.67	4.92	15.55%	14.43%
PHG Koninklijke Philips NV	$26.82	-3.36%	3.76%	19.89	1.95	9.80%	6.30%
INMD InMode Ltd.	$13.96	-8.85%	0.00%	10.69	1.32	12.32%	20.69%
BDX Becton Dickinson and Company	$195.54	7.84%	2.11%	58.16	2.24	3.85%	6.29%
DXCM DexCom Inc.	$77.98	10.88%	0.00%	30.21	11.52	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.05	18.33%	0.00%	51.22	4.80	9.37%	15.43%
ALGN Align Technology Inc.	$152.59	12.85%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$30.55	-13.56%	2.51%	23.17	5.04	21.74%	9.20%
IRMD iRadimed Corporation	$85.61	10.35%	1.47%	47.98	10.87	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$97.06	-4.54%	0.97%	23.48	1.50	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

COO - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.01%

Current Payout

—

5-year average Payout

0.42%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	07/25/2023	08/11/2023	0.007500
Dividends	01/19/2023	02/10/2023	0.007500
Dividends	07/25/2022	08/11/2022	0.007500
Dividends	01/19/2022	02/09/2022	0.007500
Dividends	07/23/2021	08/11/2021	0.007500
Dividends	01/20/2021	02/09/2021	0.007500
Dividends	07/21/2020	08/07/2020	0.007500
Dividends	01/21/2020	02/10/2020	0.007500
Dividends	07/19/2019	08/07/2019	0.007500
Dividends	01/18/2019	02/08/2019	0.007500
Dividends	07/19/2018	08/07/2018	0.007500
Dividends	01/19/2018	02/09/2018	0.007500
Dividends	07/19/2017	08/07/2017	0.007500
Dividends	01/19/2017	02/09/2017	0.007500
Dividends	07/20/2016	08/05/2016	0.007500
Dividends	01/20/2016	02/09/2016	0.007500
Dividends	07/22/2015	08/06/2015	0.007500
Dividends	01/21/2015	02/09/2015	0.007500
Dividends	07/22/2014	08/06/2014	0.007500
Dividends	01/22/2014	02/07/2014	0.007500
Dividends	07/22/2013	08/06/2013	0.007500
Dividends	01/23/2013	02/07/2013	0.007500
Dividends	07/20/2012	08/06/2012	0.007500
Dividends	01/23/2012	02/07/2012	0.007500
Dividends	07/21/2011	08/05/2011	0.007500
Dividends	01/17/2011	02/07/2011	0.007500
Dividends	07/16/2010	08/05/2010	0.007500
Dividends	01/15/2010	02/05/2010	0.007500
Dividends	07/16/2009	08/05/2009	0.007500
Dividends	01/15/2009	02/05/2009	0.007500
Dividends	06/11/2008	07/03/2008	0.007500
Dividends	12/12/2007	01/04/2008	0.007500
Dividends	06/11/2007	07/05/2007	0.007500
Dividends	12/13/2006	01/05/2007	0.007500
Dividends	06/12/2006	07/05/2006	0.007500
Dividends	12/14/2005	01/05/2006	0.007500
Dividends	06/10/2005	07/05/2005	0.007500
Dividends	12/14/2004	01/05/2005	0.007500
Dividends	06/10/2004	07/06/2004	0.007500
Dividends	12/15/2003	01/05/2004	0.007500
Dividends	06/11/2003	07/03/2003	0.007500
Dividends	12/12/2002	01/06/2003	0.007500
Dividends	06/11/2002	07/03/2002	0.006250
Dividends	12/12/2001	01/04/2002	0.006250
Dividends	06/13/2001	07/05/2001	0.006250
Dividends	12/13/2000	01/05/2001	0.002500
Dividends	09/13/2000	10/05/2000	0.002500
Dividends	06/13/2000	07/05/2000	0.002500
Dividends	03/13/2000	04/05/2000	0.002500
Dividends	12/13/1999	01/05/2000	0.002500
Dividends	09/13/1999	10/05/1999	0.002500
Dividends	06/11/1999	07/05/1999	0.002500

ABOUT Cooper Companies

Cooper Companies Inc.

Average Investor10 user rating

4.0 (0 people)

United States

46 years

Founded: 1980

1983

Time since IPO - 43 years

12.000

Employees

Cooper Companies Inc. (United States) is listed on the NYSE and has a market capitalization of $11.83 billion, with shareholders equity totaling $8.33 billion.

The company employs approximately 12.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Cooper Companies Inc. reported $4.24 billion in revenue, generating net income of $570.30 million.

Key financial metrics include a P/E ratio of 20.73, a price-to-book (P/B) ratio of 1.42, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker COO.

Market cap

$11.83 billion

Net worth

$8.33 billion

$8,328,400,000.00

Assets

$12.67 billion

$12,673,400,000.00

Total Shares Outstanding

193.00 million

193,000,000

Average Daily Trading Volume

$3.73 million

$3,731,385.80

Sector

Health

Industry

Medical Supplies and Equipment

COO

COO revenue and profits

Financial Results COO

DRAG THE FRAME TO SEE MORE DATA

COO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$92.51 17,32% (12M)

P/E

24.33

2.86%

ROE

6.12%

P/BV

1.49

CI - Cigna

$306.21 3,76% (12M)

P/E

11.94

2.00%

ROE

16.04%

P/BV

1.92

CNC - Centene

$67.78 98,94% (12M)

P/E

-6.87

0.00%

ROE

-22.53%

P/BV

1.55

HUM - Humana

$419.80 46,83% (12M)

P/E

39.79

0.84%

ROE

6.63%

P/BV

2.64

SNY - Sanofi

$41.59 --16,30% (12M)

P/E

3.88

4.26%

ROE

18.43%

P/BV

0.72

JNJ - Johnson & Johnson

$266.02 43,64% (12M)

P/E

39.76

2.02%

ROE

19.74%

P/BV

7.85

LLY - Eli Lilly

$1,282.23 56,32% (12M)

P/E

42.82

0.52%

ROE

78.84%

P/BV

33.76

HCA - HCA Healthcare

$467.51 5,08% (12M)

P/E

15.24

0.65%

ROE

-213.15%

P/BV

-32.49